Cheryl Stucky, PhD
Professor of Cell Biology, Neurobiology & Anatomy
Director, Neuroscience Doctoral Program
Medical College of Wisconsin
In virtually all of our daily activities, we rely on our skin and nervous system to interact with the world around us. Our laboratory is keenly interested in how our skin sensory neurons detect environmental stimuli, such as tactile pressure, cold and heat, and painful stimuli. The best candidate proteins for transduction of physical stimuli are members of the Transient Receptor Potential ion channel family. For example, we recently showed that the Transient Receptor Potential Melastatin 8 (TRPM8), the receptor activated by menthol and peppermint, is a key receptor that detects cool and painfully cold stimuli (Bautista et al., 2007, Nature).
The purpose of the Action Learning Collaborative (ALC) is to accelerate collaboration among interested colleagues across organizations, sectors, disciplines, and perspectives to address challenges to greater use of LARC in our community as an effective prevention strategy for women’s health.
The ALC is made up of small teams of colleagues who agree to work together, with support and assistance from PCI Staff over 2 – 3 months. Together teams have the capacity to suggest recommendations for overcoming leading barriers identified by diverse stakeholders at the June 2015 PCI Action Learning Workshop. Individuals are encouraged to register, indicating one, two, and/or three themes they would like to pursue further. The PCI staff will facilitate opportunities for groups to form and participate in ‘barrier busting’ strategies.
Registration due by Friday, September 11.
Associate Professor; Surgical Director, Cincinnati Fetal Center
Cincinnati Children’s Hospital Medical Center
University of Cincinnati College of Medicine
Foong-Yen Lim, MD, a pediatric and fetal surgeon, leads the Fetal Team as the Surgical Director of the Cincinnati Fetal Center (CFC). He has performed more than 500 fetoscopic procedures and various open fetal surgeries at CFC. Besides his leadership role locally, he currently serves on the Fetal Diagnosis and Treatment Committee of the American Pediatric Surgical Association; and Board of Directors of the North American Fetal Therapy (NAFTNet). He also served as the Program Director of the 30th Annual International Fetal Medicine and Surgery Society (IFMSS) Conference.
Dr. Lim continues to expand his expertise in Pediatric General and Thoracic Surgery with an emphasis on congenital diaphragmatic hernia (CDH); congenital lung lesions such as congenital pulmonary airway malformation (CPAM) and bronchopulmonary sequestration (BPS); congenital high airway obstruction syndrome (CHAOS); and congenital tumors including giant cervical teratoma, and sacrococcygeal teratoma. In addition to serving as one of the attending physicians on the CDH Team that is dedicated to the care and management of all CDH patients, he is leading the clinical and research projects related to CDH and congenital lung lesions at Cincinnati.
Dr. Lim leads the Cincinnati Fetal Center Perinatal Research Group in clinical research with currently over thirty active IRB protocols. Together with the staff in Cincinnati Fetal Center, we are building a comprehensive data base for all of our patients to facilitate outcomes report and study. At Cincinnati Children’s, Dr. Lim collaborates with physicians and researchers at the Perinatal Institute, The Heart Institute, Division of Pulmonary Biology, Division of Radiology, Division of Otolaryngology, Division of Anesthesia, Division of Urology, and the Division of Pediatric General and Thoracic Surgery in various projects. The Cincinnati Fetal Center is also collaborating with physicians and researchers at the University Hospital and Good Samaritan Hospital in various projects. We also have robust involvement in multicenter trials, registries and projects such as International Stage I TTTS Trial, International Prenatal Tracheal Occlusion Trial for Severe CDH, DHREAMS (Diaphragmatic Hernia Research & Exploration; Advancing Molecular Science) study (NIH grant HD057036), International CDH Registry, North America registry for pregnancies complicated by prenatally diagnosed lower urinary tract obstruction (LUTO) with normal amniotic fluid volume, and NAFTNet-sponsor projects including “Natural history of Stage I Twin-Twin Transfusion Syndrome” and “Delivery indications for TTTS after laser ablation”; just to name a few.
Innovation of prenatal diagnosis and in utero treatment are the mainstay of the Lim lab. The ability to diagnose congenital conditions prior to birth has led to an opportunity to understand the natural history of these processes and provide antenatal therapy to prevent devastating morbidities and even death. While much of our focus is on risk stratification using prenatal evaluations and the development of prognostic indicators, we are also actively investigating the role of prenatal biomarkers that may provide insight into the development and progression of these fetal anomalies. The advancement and innovation of operative techniques can then be performed in animal models with translation into patient use.
The purpose of the Action Learning Collaborative (ALC) is to accelerate collaboration among interested colleagues across organizations, sectors, disciplines, and perspectives to address challenges to greater use of LARC in our community as an effective prevention strategy for women’s health.
The ALC is made up of small teams of colleagues who agree to work together, with support and assistance from PCI Staff over 2 – 3 months. Together teams have the capacity to suggest recommendations for overcoming leading barriers identified by diverse stakeholders at the June 2015 PCI Action Learning Workshop. Individuals are encouraged to register, indicating one, two, and/or three themes they would like to pursue further. The PCI staff will facilitate opportunities for groups to form and participate in ‘barrier busting’ strategies.
Readiness Session Registration due by Friday, September 11.
Ling Wang, MD, PhD
Instructor
Department of Obstetrics & Gynecology
Medical College of Wisconsin
Dr. Wang’s. has extensive experience in tumor angiogenesis and tumor biology. Her long-term research interests involve the development of a comprehensive understanding of the molecular mechanisms and the molecule-based diagnosis and therapy to woman cancer. Her study in neuropilin biology determines the status of neuropilin-1/GIPC (RGS-GAIP-interacting protein) signaling in vascular development and tumor progression. Currently, she is focused on to identify the role of microenvironment and germline BRCA1 mutation in breast cancer and ovarian cancer metastases, with specific emphasis on the signaling mechanisms and clinical significance.
Katherine Schoyer, MD, reproductive medicine and Amy Granlund, BS, embryologist & laboratory coordinator we will present both the clinical and embryology laboratory methods to help give patients the best likelihood of having a baby from IVF, and how our embryologists and physicians work together toward this goal.
Register online by going to Froedtert Health’s Classes and Events
Weiguo Cui, PhD
Associate Investigator
Blood Research Institute
BloodCenter of Wisconsin
Assistant Professor
Department of Microbiology and Molecular Genetics
Medical College of Wisconsin
During an acute viral or bacterial infection, naïve T cells can differentiate into multiple types of effector and memory T cells that help to mediate pathogen clearance and provide long-term protective immunity. The main goal of our research in the lab is to elucidate how TCR and cytokine signaling and their downstream transcriptional programs regulate pathogen-specific T cells to proliferate, differentiate into either short-lived effector cells or long-lived memory cells.
Erin Bishop, MD, gynecologic oncologist, will discuss which gynecological malignancies have been linked to genetics and the importance of knowing about your family history for appropriate cancer screening.
Register online by going to Froedtert Health’s Classes and Events
Dr. Gloria Halverson, former OBGYN physician, will be presenting at MCW’s Global Health Week.
MCW Global Health Week is an opportunity to co-promote the diverse communities our faculty, staff, and partners are serving to advance health. We anticipate that together, we can continue to share credible, collaborative, and mutually beneficial efforts in global health from neighborhoods to nations.
All events are co-sponsored by MCW departments, offices and centers. Topic areas intentionally cross all of our missions of clinical care, research, education and community engagement.
Sandra Hunter, PhD and Meredith Cruz, MD, MBA/MPH
Dr. Hunter’s current research areas:
Dr. Cruz specializes in Maternal Fetal Medicine with an emphasis on critical care and high risk obstetrics, prenatal diagnosis, and ultrasonography. Her other areas of expertise include hypertension, diabetes, and cardiac issues in pregnancy.
Learn how family history and personal risk factors increase the risk for developing pancreatic cancer. Find out what options are available for the early detection and prevention of pancreatic cancer.
Register online by going to Froedtert Health’s Classes and Events
HPV (human papillomavirus) is related to the development of vulvar, vaginal and cervical cancer in women. Join us as we discuss prevention, diagnosis and management of this virus.
Register online by going to Froedtert Health’s Classes and Events